共 63 条
- [1] Blennow K(2006)Alzheimer's disease Lancet 368 387-403
- [2] De Leon MJ(2001)Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment and Early-Stage Alzheimer's Disease J Mol Neurosci 17 101-118
- [3] Zetterberg H(2009)Synaptic degeneration in Alzheimer's disease Acta Neuropathol 118 167-79
- [4] Morris JC(2009)Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain Arch Neurol 66 382-9
- [5] Price JL(2012)Le The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer's Disease Mol Diagn Ther 16 135-141
- [6] Arendt T(1993)Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme-Linked Immunosorbent Assay J Neurochem 61 1828-1834
- [7] Tapiola T(2000)Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization Neurosci Lett 285 49-52
- [8] Engelborghs S(2001)Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice Arch Neurol 58 373-9
- [9] Bastard N(2012)Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort Neurology 78 47-54
- [10] Vandermeeren M(2006)Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample Neurobiol Aging 27 1202-11